We identified SERPINE1 antibodies in the sera of patients who had a transient ischemic attack (TIA) and then investigated whether the SERPINE1 antibody could serve as a novel biomarker of ischemic stroke such as acute cerebral infarction (aCI), chronic cerebral infarction (cCI), and TIA. This evidence concerns the gene SERPINE1 and ischemic stroke.